Marimastat is a synthetic, broad-spectrum matrix metalloproteinase (MMP) inhibitor that was historically investigated as an antineoplastic agent designed to block angiogenesis and inhibit tumor metastasis… Read more
Marimastat is a synthetic, broad-spectrum matrix metalloproteinase (MMP) inhibitor that was historically investigated as an antineoplastic agent designed to block angiogenesis and inhibit tumor metastasis by preventing extracellular matrix degradation. By binding to zinc ions within the active site of MMPs, the drug limits the invasive progression of malignant cells, making it a significant subject in oncological research regarding proteolytic signaling pathways. The related compounds in this category, including synthetic impurities, metabolic degradation products, and stable isotope-labelled standards, are essential for precise analytical testing. These reference standards enable laboratory professionals to conduct accurate impurity profiling, validate complex analytical methods, and perform rigorous quality control during pharmacokinetic investigations. By providing well-characterized derivatives, these materials support the development of robust assays required for monitoring drug stability and metabolism in diverse scientific and industrial research applications.